Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review
- PMID: 29447628
Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review
Abstract
The 5-α-reductase inhibitors finasteride and dutasteride are frequently used in the treatment of androgenetic alopecia and benign prostatichyperplasia. These drugs are effective at reducing levels of dihydrotestosterone, the primary androgen responsible for the pathogenesis of both these conditions. However, finasteride and dutasteride have also been shown to produce an increase in the incidence of sexual dysfunction, namely, impotence, decreased libido, and ejaculation disorder. The purpose of this study is to review the existing medical literature with regard to the sexual side effects of 5-α-reductase inhibitor therapy. This review is an extensive look at the sexual effects of 5-α-reductase inhibitors and compares outcomes for finasteride versus dutasteride in addition to comparing sexualside effects for each of the different dosages prescribed of finasteride and dutasteride.
Similar articles
-
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.Acta Derm Venereol. 2019 Jan 1;99(1):12-17. doi: 10.2340/00015555-3035. Acta Derm Venereol. 2019. PMID: 30206635
-
Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.Sex Med Rev. 2019 Apr;7(2):277-282. doi: 10.1016/j.sxmr.2018.07.003. Epub 2018 Oct 6. Sex Med Rev. 2019. PMID: 30301703 Review.
-
The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.Curr Urol Rep. 2018 Jun 16;19(8):65. doi: 10.1007/s11934-018-0814-z. Curr Urol Rep. 2018. PMID: 29909472 Review.
-
Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.Andrology. 2017 Jul;5(4):671-678. doi: 10.1111/andr.12353. Epub 2017 Apr 28. Andrology. 2017. PMID: 28453908 Review.
-
Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):47-54. doi: 10.4103/0378-6323.188652. Indian J Dermatol Venereol Leprol. 2017. PMID: 27549867 Clinical Trial.
Cited by
-
The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database.Brain Sci. 2023 Nov 29;13(12):1652. doi: 10.3390/brainsci13121652. Brain Sci. 2023. PMID: 38137101 Free PMC article.
-
Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis.Front Aging. 2023 Jun 13;4:1196648. doi: 10.3389/fragi.2023.1196648. eCollection 2023. Front Aging. 2023. PMID: 37384143 Free PMC article.
-
Effects of Allium hookeri Extracts on Hair-Inductive and Anti-Oxidative Properties in Human Dermal Papilla Cells.Plants (Basel). 2023 May 8;12(9):1919. doi: 10.3390/plants12091919. Plants (Basel). 2023. PMID: 37176977 Free PMC article.
-
5-alpha reductase inhibitors use in prostatic disease and beyond.Transl Androl Urol. 2023 Mar 31;12(3):487-496. doi: 10.21037/tau-22-690. Epub 2023 Mar 6. Transl Androl Urol. 2023. PMID: 37032761 Free PMC article. Review.
-
The Interplay between Finasteride-Induced Androgen Imbalance, Endoplasmic Reticulum Stress, Oxidative Stress, and Liver Disorders in Paternal and Filial Generation.Biomedicines. 2022 Oct 27;10(11):2725. doi: 10.3390/biomedicines10112725. Biomedicines. 2022. PMID: 36359245 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical